UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

OMB Number:  3235-0578

 

Expires:    April 30, 2013

 

Estimated average burden hours per response......5.6

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number  811- 06565

 

H&Q Life Sciences Investors

(Exact name of registrant as specified in charter)

 

2 Liberty Square, 9th Floor, Boston, MA

 

02109

(Address of principal executive offices)

 

(Zip code)

 

Laura Woodward

H&Q Life Sciences Investors

2 Liberty Square, 9th Floor, Boston MA 02109

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:  617-772-8500

 

 

Date of fiscal year end:  September 30

 

 

Date of reporting period:  7/1/11-6/30/12

 

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC  20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 



 

Item 1. Proxy Voting Record.

 



 

ACORDA THERAPEUTICS, INC.

 

Security

00484M106

 

Meeting Type

Annual

Ticker Symbol

ACOR

 

Meeting Date

06-Jun-2012

ISIN

US00484M1062

 

Agenda

933614364 - Management

Record Date

09-Apr-2012

 

Holding Recon Date

09-Apr-2012

City / Country

/

United States

Vote Deadline Date

05-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      BARRY GREENE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      IAN SMITH

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.

 

For

 

Yes

 

For

 

Management

 

ADDUS HOMECARE CORPORATION

 

Security

006739106

 

Meeting Type

Annual

Ticker Symbol

ADUS

 

Meeting Date

20-Jun-2012

ISIN

US0067391062

 

Agenda

933633516 - Management

Record Date

26-Apr-2012

 

Holding Recon Date

26-Apr-2012

City / Country

/

United States

Vote Deadline Date

19-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      MARK L. FIRST

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      R. DIRK ALLISON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE SELECTION OF BDO USA, LLP AS INDEPENDENT AUDITOR OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 



 

AEGERION PHARMACEUTICALS, INC.

 

Security

00767E102

 

Meeting Type

Annual

Ticker Symbol

AEGR

 

Meeting Date

05-Jun-2012

ISIN

US00767E1029

 

Agenda

933611647 - Management

Record Date

09-Apr-2012

 

Holding Recon Date

09-Apr-2012

City / Country

/

United States

Vote Deadline Date

04-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      SANDFORD D. SMITH

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      PAUL G. THOMAS

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS AEGERION PHARMACEUTICALS, INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

AKORN, INC.

 

Security

009728106

 

Meeting Type

Special

Ticker Symbol

AKRX

 

Meeting Date

29-Dec-2011

ISIN

US0097281069

 

Agenda

933536457 - Management

Record Date

05-Dec-2011

 

Holding Recon Date

05-Dec-2011

City / Country

/

United States

Vote Deadline Date

28-Dec-2011

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

01

 

APPROVAL OF AN AMENDMENT TO THE AMENDED AND RESTATED AKORN, INC. 2003 STOCK OPTION PLAN TO INCREASE THE TOTAL NUMBER OF SHARES OF COMMON STOCK AUTHORIZED AND RESERVED FOR ISSUANCE UNDER THE PLAN FROM 11,000,000 TO 19,000,000 SHARES.

 

For

 

Yes

 

For

 

Management

 



 

AKORN, INC.

 

Security

009728106

 

Meeting Type

Annual

Ticker Symbol

AKRX

 

Meeting Date

04-May-2012

ISIN

US0097281069

 

Agenda

933610760 - Management

Record Date

19-Mar-2012

 

Holding Recon Date

19-Mar-2012

City / Country

/

United States

Vote Deadline Date

03-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      JOHN N. KAPOOR, PHD

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      RONALD M. JOHNSON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      BRIAN TAMBI

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      STEVEN J. MEYER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      ALAN WEINSTEIN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6      KENNETH S. ABRAMOWITZ

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7      ADRIENNE L. GRAVES, PHD

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

PROPOSAL TO RATIFY THE SELECTION OF ERNST & YOUNG LLP TO SERVE AS AKORN’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

SAY ON PAY - AN ADVISORY VOTE ON APPROVAL OF THE COMPANY’S EXECUTIVE COMPENSATION PROGRAM.

 

For

 

Yes

 

For

 

Management

 

ALEXION PHARMACEUTICALS, INC.

 

Security

015351109

 

Meeting Type

Annual

Ticker Symbol

ALXN

 

Meeting Date

07-May-2012

ISIN

US0153511094

 

Agenda

933610772 - Management

Record Date

16-Mar-2012

 

Holding Recon Date

16-Mar-2012

City / Country

/

United States

Vote Deadline Date

04-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      LEONARD BELL

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      MAX LINK

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      WILLIAM R. KELLER

 

For

 

Yes

 

For

 

 

 



 

 

 

4      JOSEPH A. MADRI

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      LARRY L. MATHIS

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6      R. DOUGLAS NORBY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7      ALVIN S. PARVEN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8      ANDREAS RUMMELT

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9      ANN M. VENEMAN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS ALEXION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

APPROVAL OF A NON-BINDING ADVISORY VOTE OF THE COMPENSATION PAID TO ALEXION’S NAMED EXECUTIVE OFFICERS.

 

For

 

Yes

 

For

 

Management

 

ALKERMES PLC

 

Security

G01767105

 

Meeting Type

Special

Ticker Symbol

ALKS

 

Meeting Date

08-Dec-2011

ISIN

IE00B56GVS15

 

Agenda

933524604 - Management

Record Date

01-Nov-2011

 

Holding Recon Date

01-Nov-2011

City / Country

/

United States

Vote Deadline Date

07-Dec-2011

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

01

 

TO APPROVE THE ALKERMES PLC 2011 STOCK OPTION AND INCENTIVE PLAN.

 

For

 

Yes

 

For

 

Management

 



 

ALKERMES, INC.

 

Security

01642T108

 

Meeting Type

Special

Ticker Symbol

ALKS

 

Meeting Date

08-Sep-2011

ISIN

US01642T1088

 

Agenda

933496019 - Management

Record Date

01-Aug-2011

 

Holding Recon Date

01-Aug-2011

City / Country

/

United States

Vote Deadline Date

07-Sep-2011

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

01

 

TO ADOPT THE BUSINESS COMBINATION AGREEMENT AND PLAN OF MERGER, DATED AS OF MAY 9, 2011, BY AND AMONG ELAN CORPORATION, PLC, ALKERMES, INC., ANTLER SCIENCE TWO LIMITED, ANTLER ACQUISITION CORP. AND CERTAIN OTHER PARTIES AS DESCRIBED IN THE PROXY STATEMENT/PROSPECTUS, PURSUANT TO WHICH ANTLER ACQUISITION CORP. WILL MERGE WITH AND INTO ALKERMES, INC.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

02

 

TO APPROVE THE CREATION OF DISTRIBUTABLE RESERVES OF ALKERMES PLC THROUGH A REDUCTION OF THE SHARE PREMIUM ACCOUNT OF ALKERMES PLC (THAT WAS PREVIOUSLY APPROVED BY THE CURRENT SHAREHOLDERS OF ALKERMES PLC) AS DESCRIBED IN THE PROXY STATEMENT/PROSPECTUS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

03

 

TO ADJOURN THE SPECIAL MEETING TO A LATER DATE OR DATES IF NECESSARY OR APPROPRIATE, INCLUDING FOR THE PURPOSE OF PERMITTING FURTHER SOLICITATION OF PROXIES.

 

For

 

Yes

 

For

 

Management

 

AMARIN CORPORATION PLC

 

Security

023111206

 

Meeting Type

Annual

Ticker Symbol

AMRN

 

Meeting Date

12-Jul-2011

ISIN

US0231112063

 

Agenda

933458336 - Management

Record Date

29-Apr-2011

 

Holding Recon Date

29-Apr-2011

City / Country

/

United States

Vote Deadline Date

05-Jul-2011

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

O1

 

ORDINARY RESOLUTION TO RE-ELECT DR. JOSEPH ANDERSON AS A DIRECTOR.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O2

 

ORDINARY RESOLUTION TO RE-ELECT DR. JAMES I. HEALY AS A DIRECTOR.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O3

 

ORDINARY RESOLUTION TO ELECT MS. KRISTINE PETERSON AS A DIRECTOR.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O4

 

ORDINARY RESOLUTION TO ELECT DR. DAVID FEIGAL AS A DIRECTOR.

 

For

 

Yes

 

For

 

Management

 



 

O5

 

ORDINARY RESOLUTION (ADVISORY, NON-BINDING VOTE) ON THE COMPANY’S EXECUTIVE COMPENSATION.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O6

 

ORDINARY RESOLUTION (ADVISORY, NON-BINDING VOTE) ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.

 

1 Year

 

Yes

 

1 Year

 

Management

 

 

 

 

 

 

 

 

 

 

 

O7

 

ORDINARY RESOLUTION (ADVISORY, NON-BINDING VOTE) ON THE DIRECTORS’ REMUNERATION REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2010.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O8

 

ORDINARY RESOLUTION TO RE-APPOINT DELOITTE & TOUCHE LLP AS AUDITORS OF THE COMPANY AND TO AUTHORISE THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF THE COMPANY TO FIX THEIR REMUNERATION.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

S9

 

SPECIAL RESOLUTION TO ADOPT AND APPROVE THE AMARIN CORPORATION PLC 2011 STOCK INCENTIVE PLAN.

 

For

 

Yes

 

For

 

Management

 

AMGEN INC.

 

Security

031162100

 

Meeting Type

Annual

Ticker Symbol

AMGN

 

Meeting Date

23-May-2012

ISIN

US0311621009

 

Agenda

933583937 - Management

Record Date

26-Mar-2012

 

Holding Recon Date

26-Mar-2012

City / Country

/

United States

Vote Deadline Date

22-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote 
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1A.

 

ELECTION OF DIRECTOR: DR. DAVID BALTIMORE

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1B.

 

ELECTION OF DIRECTOR: MR. FRANK J. BIONDI, JR.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1C.

 

ELECTION OF DIRECTOR: MR. ROBERT A. BRADWAY

 

For

 

Yes

 

For

 

Management

 



 

1D.

 

ELECTION OF DIRECTOR: MR. FRANCOIS DE CARBONNEL

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1E.

 

ELECTION OF DIRECTOR: DR. VANCE D. COFFMAN

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1F.

 

ELECTION OF DIRECTOR: DR. REBECCA M. HENDERSON

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1G.

 

ELECTION OF DIRECTOR: MR. FRANK C. HERRINGER

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1H.

 

ELECTION OF DIRECTOR: DR. TYLER JACKS

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1I.

 

ELECTION OF DIRECTOR: DR. GILBERT S. OMENN

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1J.

 

ELECTION OF DIRECTOR: MS. JUDITH C. PELHAM

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1K.

 

ELECTION OF DIRECTOR: ADM. J. PAUL REASON, USN (RETIRED)

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1L.

 

ELECTION OF DIRECTOR: MR. LEONARD D. SCHAEFFER

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1M.

 

ELECTION OF DIRECTOR: MR. KEVIN W. SHARER

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1N.

 

ELECTION OF DIRECTOR: DR. RONALD D. SUGAR

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

TO APPROVE AN AMENDMENT TO OUR RESTATED CERTIFICATE OF INCORPORATION TO AUTHORIZE STOCKHOLDER ACTION BY WRITTEN CONSENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

5A.

 

STOCKHOLDER PROPOSAL #1 (INDEPENDENT CHAIRMAN OF THE BOARD).

 

Against

 

Yes

 

For

 

Shareholder

 

 

 

 

 

 

 

 

 

 

 

5B.

 

STOCKHOLDER PROPOSAL #2 (TRANSPARENCY IN ANIMAL USE).

 

Against

 

Yes

 

Against

 

Shareholder

 

 

 

 

 

 

 

 

 

 

 

5C.

 

STOCKHOLDER PROPOSAL #3 (REQUEST FOR DISCLOSURE OF LOBBYING POLICIES AND PRACTICES).

 

Against

 

Yes

 

Against

 

Shareholder

 

 

 

 

 

 

 

 

 

 

 

5D.

 

STOCKHOLDER PROPOSAL #4 (CEO TO SERVE ON A MAXIMUM OF ONE OTHER BOARD).

 

Against

 

Yes

 

Against

 

Shareholder

 



 

BIOGEN IDEC INC.

 

Security

09062X103

 

Meeting Type

Annual

Ticker Symbol

BIIB

 

Meeting Date

08-Jun-2012

ISIN

US09062X1037

 

Agenda

933618843 - Management

Record Date

10-Apr-2012

 

Holding Recon Date

10-Apr-2012

City / Country

/

United States

Vote Deadline Date

07-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1A.

 

ELECTION OF DIRECTOR: CAROLINE D. DORSA

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1B.

 

ELECTION OF DIRECTOR: STELIOS PAPADOPOULOS

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1C.

 

ELECTION OF DIRECTOR: GEORGE A. SCANGOS

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1D.

 

ELECTION OF DIRECTOR: LYNN SCHENK

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1E.

 

ELECTION OF DIRECTOR: ALEXANDER J. DENNER

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1F.

 

ELECTION OF DIRECTOR: NANCY L. LEAMING

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1G.

 

ELECTION OF DIRECTOR: RICHARD C. MULLIGAN

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1H.

 

ELECTION OF DIRECTOR: ROBERT W. PANGIA

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1I.

 

ELECTION OF DIRECTOR: BRIAN S. POSNER

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1J.

 

ELECTION OF DIRECTOR: ERIC K. ROWINSKY

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1K.

 

ELECTION OF DIRECTOR: STEPHEN A. SHERWIN

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1L.

 

ELECTION OF DIRECTOR: WILLIAM D. YOUNG

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS BIOGEN IDEC’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

SAY ON PAY - AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.

 

For

 

Yes

 

For

 

Management

 



 

4.

 

TO APPROVE AN AMENDMENT TO BIOGEN IDEC’S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ESTABLISHING DELAWARE AS EXCLUSIVE FORUM FOR CERTAIN DISPUTES.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

5.

 

TO APPROVE AN AMENDMENT TO BIOGEN IDEC’S SECOND AMENDED AND RESTATED BYLAWS PERMITTING HOLDERS OF AT LEAST 25% OF COMMON STOCK TO CALL SPECIAL MEETINGS.

 

For

 

Yes

 

For

 

Management

 

BRUKER CORPORATION

 

Security

116794108

 

Meeting Type

Annual

Ticker Symbol

BRKR

 

Meeting Date

18-May-2012

ISIN

US1167941087

 

Agenda

933602636 - Management

Record Date

30-Mar-2012

 

Holding Recon Date

30-Mar-2012

City / Country

/

United States

Vote Deadline Date

17-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      RICHARD D. KNISS

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      JOERG C. LAUKIEN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      WILLIAM A. LINTON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      CHRIS VAN INGEN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO CONSIDER AND ACT UPON A PROPOSAL TO RATIFY, CONFIRM AND APPROVE THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF BRUKER CORPORATION FOR FISCAL 2012.

 

For

 

Yes

 

For

 

Management

 

CARDIOKINETIX, INC.

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

14-Sep-11

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

APPROVE THE AMENDMENT AND RESTATED CERTIFICATE OF INCORPORATION

 

For

 

Yes

 

For

 

Management

2

 

APPROVE THE SALE AND ISSUANCE OF SERIES E PREFFERED STOCK

 

For

 

Yes

 

For

 

Management

3

 

APPROVE WAVIER OF RIGHT OF FIRST OFFER

 

For

 

Yes

 

For

 

Management

4

 

APPROVE THE AMENDMENT TO THE 2002 STOCK PLAN

 

For

 

Yes

 

For

 

Management

5

 

ELECT DIRECTORS PAUL LA VIOLETTE AND JEANI DELAGARDELLE

 

For

 

Yes

 

For

 

Management

6

 

APPROVE THE AMENDED AND RESTATED FORM OF IDEMNIFICATION AGREEMENT

 

For

 

Yes

 

For

 

Management

7

 

APPROVE AMENDMENTS TO THE BYLAWS

 

For

 

Yes

 

For

 

Management

8

 

APPROVE THE WAIVER OF ANTI-DILUTION ADJUSTMENTS

 

For

 

Yes

 

For

 

Management

9

 

APPROVE OMNIBUS RESOLUTION

 

For

 

Yes

 

For

 

Management

 

CARDIOKINETIX, INC

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

28-Feb-12

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

RATIFICATION OF THE AMENDMENT TO THE 2002 STOCK PLAN

 

For

 

Yes

 

For

 

Management

2

 

APPROVE THE AMENDED AND RESTATED 2002 STOCK PLAN

 

For

 

Yes

 

For

 

Management

3

 

ADOPTION OF THE 2011 EQUITY INCENTIVE PLAN

 

For

 

Yes

 

For

 

Management

4

 

WAVIER ANTI-DILUTION AND PROTECTIVE PROVISIONS

 

For

 

Yes

 

For

 

Management

5

 

WAVIER OF RIGHT OF FIRST OFFER

 

For

 

Yes

 

For

 

Management

6

 

APPROVE OMNIBUS RESOLUTION

 

For

 

Yes

 

For

 

Management

 



 

CELGENE CORPORATION

 

Security

151020104

 

Meeting Type

Annual

Ticker Symbol

CELG

 

Meeting Date

13-Jun-2012

ISIN

US1510201049

 

Agenda

933620189 - Management

Record Date

18-Apr-2012

 

Holding Recon Date

18-Apr-2012

City / Country

/

United States

Vote Deadline Date

12-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      ROBERT J. HUGIN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      R.W. BARKER, D. PHIL.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      MICHAEL D. CASEY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      CARRIE S. COX

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      RODMAN L. DRAKE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6      M.A. FRIEDMAN, M.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7      GILLA KAPLAN, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8      JAMES J. LOUGHLIN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9      ERNEST MARIO, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

APPROVAL OF AN AMENDMENT TO THE COMPANY’S 2008 STOCK INCENTIVE PLAN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

5.

 

STOCKHOLDER PROPOSAL DESCRIBED IN MORE DETAIL IN THE PROXY STATEMENT.

 

Against

 

Yes

 

Against

 

Shareholder

 

CELLADON CORPORATION

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

26-Apr-12

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

APPROVE THE AMENDMENT TO THE COMPANY’S 2012 EQUITY INCENTIVE PLAN.

 

For

 

Yes

 

For

 

Management

 

CERES, INC.

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

9-Dec-11

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

APPROVAL OF ALL AMENDMENTS TO THE CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION

 

For

 

Yes

 

For

 

Management

2

 

APPROVAL OF THE SPONSORED RESARCH AGREEMENT WITH TEXAS A&M UNIVERSITY (TAMU)

 

For

 

Yes

 

For

 

Management

3

 

APPROVAL TO ISSUE TAMU WARRANT TO PURCHASE SHARES OF THE CORPORATIONS’S COMMON STOCK

 

For

 

Yes

 

For

 

Management

4

 

AUTHORIZATION AND ISSUANCE OF ANY EQUITY SECURITY BY THE CORPORATION PURSUANT TO THE CORPORATION’S RESTATED CERTIFICATE OF INCORPORATION

 

For

 

Yes

 

For

 

Management

5

 

APPROVAL AND CONSENT TO THE ISSUANCE OF WARRANTS TO PURCHASE UP TO AN AGGREGATE OF 200,000 SHARES OF THE CORPORATIONS COMMON STOCK TO TAMU

 

For

 

Yes

 

For

 

Management

6

 

APPROVAL THAT THE OFFICERS OF THE CORPORATION BE AUTHORIZED AND DIRECTED ON BEHALF OF THE CORPORATION, TO EXECUTE ALL DOCUMENTS AND TAKE SUCH FURTHER ACTION AS THEY DEEM NECESSARY, APPROPRIATE OR ADVISABLE.

 

For

 

Yes

 

For

 

Management

7

 

CONVERTIBLE NOTE OFFERING WAIVER

 

For

 

Yes

 

For

 

Management

8

 

AUTHORIZATION TO ISSUE AND SELL CONVERTIBLE NOTES

 

For

 

Yes

 

For

 

Management

9

 

WAIVER AND CONSENT

 

For

 

Yes

 

For

 

Management

 

CERES, INC.

 

Security

N/A

 

Meeting Type

Annual

Ticker Symbol

N/A

 

Meeting Date

17-Jan-12

Record Date

14-Dec-11

 

 

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

TO ELECT ELEVEN DIRECTORS TO SERVE UNTIL THE 2013 ANNUAL STOCKHOLDERS MEETING

 

For

 

Yes

 

For

 

Management

2

 

TO RATIFY KPMG AS INDEPENDENT ACCOUNTANTS FOR THE FISCAL YEAR.

 

For

 

Yes

 

For

 

Management

3

 

TO CONSIDER OTHER SUCH BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING

 

For

 

Yes

 

For

 

Management

 

CONCENTRIC MEDICAL, INC.

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

31-Aug-11

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

ADOPTION OF THE MERGER DOCUMENTS

 

For

 

Yes

 

For

 

Management

2

 

CONSENTS AND TERMINATION OF OTHER AGREEMENTS

 

For

 

Yes

 

For

 

Management

3

 

CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

For

 

Yes

 

For

 

Management

4

 

OMNIBUS RESOLUTIONS

 

For

 

Yes

 

For

 

Management

 



 

CORNERSTONE THERAPEUTICS INC

 

Security

21924P103

 

Meeting Type

Annual

Ticker Symbol

CRTX

 

Meeting Date

22-May-2012

ISIN

US21924P1030

 

Agenda

933610859 - Management

Record Date

30-Mar-2012

 

Holding Recon Date

30-Mar-2012

City / Country

/

United States

Vote Deadline Date

21-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      CRAIG A. COLLARD

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      ALESSANDRO CHIESI

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      CHRISTOPHER CODEANNE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      MICHAEL ENRIGHT

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      ANTON GIORGIO FAILLA

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6      JAMES HARPER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7      MICHAEL HEFFERNAN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8      ROBERT M. STEPHAN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9      MARCO VECCHIA

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

RATIFICATION OF THE SELECTION BY THE AUDIT COMMITTEE OF ERNST AND YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

COVANCE INC.

 

Security

222816100

 

Meeting Type

Annual

Ticker Symbol

CVD

 

Meeting Date

08-May-2012

ISIN

US2228161004

 

Agenda

933573049 - Management

Record Date

14-Mar-2012

 

Holding Recon Date

14-Mar-2012

City / Country

/

United States

Vote Deadline Date

07-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      R. BARCHI, M.D., PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      JOSEPH C. SCODARI

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

ADVISORY APPROVAL OF THE COMPANY’S EXECUTIVE COMPENSATION.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

APPROVAL OF THE NON-EMPLOYEE DIRECTORS DEFERRED STOCK PLAN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLC FOR THE FISCAL YEAR 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

5.

 

SHAREHOLDER PROPOSAL SUBMITTED BY PETA TO REQUIRE ANNUAL REPORTS BY THE BOARD OF DIRECTORS PERTAINING TO CITATIONS UNDER THE ANIMAL WELFARE ACT.

 

Against

 

Yes

 

Against

 

Shareholder

 



 

CURIS, INC.

 

Security

231269101

 

Meeting Type

Annual

Ticker Symbol

CRIS

 

Meeting Date

30-May-2012

ISIN

US2312691015

 

Agenda

933599714 - Management

Record Date

02-Apr-2012

 

Holding Recon Date

02-Apr-2012

City / Country

/

United States

Vote Deadline Date

29-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      JAMES R. MCNAB, JR.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      JAMES R. TOBIN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR.

 

For

 

Yes

 

For

 

Management

 

DENDREON CORPORATION

 

Security

24823Q107

 

Meeting Type

Annual

Ticker Symbol

DNDN

 

Meeting Date

13-Jun-2012

ISIN

US24823Q1076

 

Agenda

933624303 - Management

Record Date

18-Apr-2012

 

Holding Recon Date

18-Apr-2012

City / Country

/

United States

Vote Deadline Date

12-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.1

 

ELECTION OF DIRECTOR: JOHN H. JOHNSON

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1.2

 

ELECTION OF DIRECTOR: SUSAN B. BAYH

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1.3

 

ELECTION OF DIRECTOR: DENNIS M. FENTON, PH.D.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1.4

 

ELECTION OF DIRECTOR: DAVID L. URDAL, PH.D.

 

For

 

Yes

 

For

 

Management

 



 

2.

 

TO APPROVE AN AMENDMENT TO THE DENDREON CORPORATION 2009 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE THEREUNDER FROM 13,200,000 TO 22,200,000.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

ELAN CORPORATION, PLC

 

Security

284131208

 

Meeting Type

Annual

Ticker Symbol

ELN

 

Meeting Date

24-May-2012

ISIN

US2841312083

 

Agenda

933623046 - Management

Record Date

16-Apr-2012

 

Holding Recon Date

16-Apr-2012

City / Country

/

United States

Vote Deadline Date

17-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

O1

 

TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS, DIRECTORS REPORT AND AUDITORS REPORT FOR THE YEAR ENDED 31 DECEMBER 2011.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O2

 

TO RE-ELECT DR. LARS EKMAN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O3

 

TO ELECT MR. HANS PETER HASLER.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O4

 

TO RE-ELECT MR. ROBERT INGRAM.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O5

 

TO RE-ELECT MR. GARY KENNEDY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O6

 

TO RE-ELECT MR. PATRICK KENNEDY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O7

 

TO RE-ELECT MR. GILES KERR.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O8

 

TO RE-ELECT MR. KELLY MARTIN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O9

 

TO RE-ELECT MR. KIERAN MCGOWAN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O10

 

TO RE-ELECT MR. KYRAN MCLAUGHLIN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O11

 

TO RE-ELECT MR. DONAL O’CONNOR.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O12

 

TO RE-ELECT MR. RICHARD PILNIK.

 

For

 

Yes

 

For

 

Management

 



 

O13

 

TO RE-ELECT DR. DENNIS SELKOE.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O14

 

TO ELECT DR. ANDREW VON ESCHENBACH.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O15

 

TO AUTHORISE THE DIRECTORS TO FIX THE REMUNERATION OF THE AUDITORS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O16

 

TO APPROVE AND ADOPT THE ELAN CORPORATION, PLC 2012 LONG TERM INCENTIVE PLAN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O17

 

TO APPROVE AND ADOPT THE ELAN CORPORATION, PLC EMPLOYEE EQUITY PURCHASE PLAN (2012 AMENDMENT).

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O18

 

TO AUTHORISE THE DIRECTORS TO ALLOT AND ISSUE RELEVANT SECURITIES.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

S19

 

TO AUTHORISE THE DISAPPLICATION OF PRE-EMPTION RIGHTS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

S20

 

TO REDUCE THE COMPANY’S SHARE CAPITAL.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

S21

 

TO CONVERT THE EXECUTIVE SHARES TO REDEEMABLE EXECUTIVE SHARES.

 

For

 

N/A

 

Abstain

 

Management

 

 

 

 

 

 

 

 

 

 

 

S22

 

TO AMEND THE ARTICLES OF ASSOCIATION.

 

For

 

N/A

 

Abstain

 

Management

 

 

 

 

 

 

 

 

 

 

 

S23

 

TO AUTHORISE THE COMPANY TO MAKE MARKET PURCHASES OF ITS OWN SHARES.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

S24

 

TO SET THE RE-ISSUE PRICE RANGE FOR TREASURY SHARES.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

S25

 

TO RETAIN A 14 DAY NOTICE PERIOD FOR EXTRAORDINARY GENERAL MEETINGS.

 

For

 

Yes

 

For

 

Management

 

ENDO PHARMACEUTICALS HOLDINGS INC.

 

Security

29264F205

 

Meeting Type

Annual

Ticker Symbol

ENDP

 

Meeting Date

23-May-2012

ISIN

US29264F2056

 

Agenda

933623957 - Management

Record Date

09-Apr-2012

 

Holding Recon Date

09-Apr-2012

City / Country

/

United States

Vote Deadline Date

22-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1A.

 

ELECTION OF DIRECTOR: ROGER H. KIMMEL

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1B.

 

ELECTION OF DIRECTOR: JOHN J. DELUCCA

 

For

 

Yes

 

For

 

Management

 



 

1C.

 

ELECTION OF DIRECTOR: DAVID P. HOLVECK

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1D.

 

ELECTION OF DIRECTOR: NANCY J. HUTSON, PH.D.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1E.

 

ELECTION OF DIRECTOR: MICHAEL HYATT

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1F.

 

ELECTION OF DIRECTOR: WILLIAM P. MONTAGUE

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1G.

 

ELECTION OF DIRECTOR: DAVID B. NASH, M.D., M.B.A.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1H.

 

ELECTION OF DIRECTOR: JOSEPH C. SCODARI

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1I.

 

ELECTION OF DIRECTOR: WILLIAM F. SPENGLER

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO APPROVE, BY ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

TO APPROVE THE AMENDMENT AND RESTATEMENT TO THE COMPANY’S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO CHANGE THE NAME OF THE COMPANY TO ENDO HEALTH SOLUTIONS INC.

 

For

 

Yes

 

For

 

Management

 

GEN-PROBE INCORPORATED

 

Security

36866T103

 

Meeting Type

Annual

Ticker Symbol

GPRO

 

Meeting Date

17-May-2012

ISIN

US36866T1034

 

Agenda

933591213 - Management

Record Date

23-Mar-2012

 

Holding Recon Date

23-Mar-2012

City / Country

/

United States

Vote Deadline Date

16-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      JOHN W. BROWN

 

For

 

Yes

 

For

 

 

 



 

 

 

2      JOHN C. MARTIN, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE GEN-PROBE INCORPORATED EMPLOYEE STOCK PURCHASE PLAN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO APPROVE THE GEN-PROBE INCORPORATED 2012 EXECUTIVE BONUS PLAN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS OF GEN-PROBE INCORPORATED.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

5.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GEN-PROBE INCORPORATED FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

GENTIUM S.P.A

 

Security

37250B104

 

Meeting Type

Annual

Ticker Symbol

GENT

 

Meeting Date

09-May-2012

ISIN

US37250B1044

 

Agenda

933576095 - Management

Record Date

29-Feb-2012

 

Holding Recon Date

29-Feb-2012

City / Country

/

United States

Vote Deadline Date

30-Apr-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

APPROVAL OF THE 2011 ITALIAN GAAP FINANCIAL STATEMENTS AND RELATED DOCUMENTS AND ALLOCATION OF THE ANNUAL OPERATING PROFIT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.A

 

ELECTION OF DIRECTOR: GIGLIOLA BERTOGLIO

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.B

 

ELECTION OF DIRECTOR: MARCO BRUGHERA

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.C

 

ELECTION OF DIRECTOR: GLENN COOPER

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.D

 

ELECTION OF DIRECTOR: LAURA FERRO

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.E

 

ELECTION OF DIRECTOR: KHALID ISLAM

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.F

 

ELECTION OF DIRECTOR: BOBBY SANDAGE

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.G

 

ELECTION OF DIRECTOR: ELMAR SCHNEE

 

For

 

Yes

 

For

 

Management

 



 

3.

 

APPROVE DIRECTOR COMPENSATION FOR THE 2012/2013 TERM.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

ELECT MEMBERS OF THE BOARD OF STATUTORY AUDITORS OF THE COMPANY FOR THE 2012/2015 TERM AND APPROVE THEIR COMPENSATION FOR SUCH TERM.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

5.

 

APPROVE THE ENGAGEMENT OF RECONTA ERNST & YOUNG S.P.A. AS THE INDEPENDENT AUDITOR FOR FISCAL YEAR 2012 WITH RESPECT TO THE COMPANY’S U.S. GAAP FINANCIAL STATEMENTS & ITS COMPENSATION.

 

For

 

Yes

 

For

 

Management

 

GILEAD SCIENCES, INC.

 

Security

375558103

 

Meeting Type

Annual

Ticker Symbol

GILD

 

Meeting Date

10-May-2012

ISIN

US3755581036

 

Agenda

933574483 - Management

Record Date

14-Mar-2012

 

Holding Recon Date

14-Mar-2012

City / Country

/

United States

Vote Deadline Date

09-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      JOHN F. COGAN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      ETIENNE F. DAVIGNON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      JAMES M. DENNY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      CARLA A. HILLS

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      KEVIN E. LOFTON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6      JOHN W. MADIGAN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7      JOHN C. MARTIN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8      GORDON E. MOORE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9      NICHOLAS G. MOORE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10    RICHARD J. WHITLEY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11    GAYLE E. WILSON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12    PER WOLD-OLSEN

 

For

 

Yes

 

For

 

 

 



 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF GILEAD’S NAMED EXECUTIVE OFFICERS AS PRESENTED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

IF PROPERLY PRESENTED AT THE MEETING, TO VOTE ON A STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD TAKE STEPS TO PERMIT STOCKHOLDER ACTION BY WRITTEN CONSENT.

 

Against

 

Yes

 

Abstain

 

Shareholder

 

 

 

 

 

 

 

 

 

 

 

5.

 

IF PROPERLY PRESENTED AT THE MEETING, TO VOTE ON A STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD TAKE STEPS TO REDEEM GILEAD’S POISON PILL UNLESS THE PLAN IS SUBJECT TO A STOCKHOLDER VOTE.

 

Against

 

Yes

 

Abstain

 

Shareholder

 

HUMAN GENOME SCIENCES, INC.

 

Security

444903108

 

Meeting Type

Annual

Ticker Symbol

HGSI

 

Meeting Date

16-May-2012

ISIN

US4449031081

 

Agenda

933584698 - Management

Record Date

23-Mar-2012

 

Holding Recon Date

23-Mar-2012

City / Country

/

United States

Vote Deadline Date

15-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      ALLAN BAXTER, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      RICHARD J. DANZIG

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      COLIN GODDARD, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      MAXINE GOWEN, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      TUAN HA-NGOC

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6      JERRY KARABELAS, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7      J.L. LAMATTINA, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8      AUGUSTINE LAW LOR

 

For

 

Yes

 

For

 

 

 



 

 

 

9      GEORGE J. MORROW

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10    GREGORY NORDEN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11    H. THOMAS WATKINS

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12    ROBERT C. YOUNG, M.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS.

 

For

 

Yes

 

Against

 

Management

 

ICAD, INC

 

Security

44934S107

 

Meeting Type

Annual

Ticker Symbol

ICAD

 

Meeting Date

22-May-12

Record Date

30-Mar-12

 

 

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

TO ELECT DR. LAWRENCE HOWARD

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT KENNETH FERRY

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT DR. RACHEL BREM

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT ANTHONY ECOCK

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT MICHAEL KLEIN

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT STEVEN RAPPAPORT

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT SOMU SUBRAMANIAM

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT DR. ELLIOT SUSSMAN

 

For

 

Yes

 

For

 

Management

2

 

APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT

 

For

 

Yes

 

For

 

Management

3

 

APPROVE THE 2012 STOCK INCENTIVE PLAN

 

For

 

Yes

 

For

 

Management

4

 

TO RATIFY BDO USA, LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012

 

For

 

Yes

 

For

 

Management

5

 

TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING

 

For

 

Yes

 

For

 

Management

 

ILLUMINA, INC.

 

Security

452327109

 

Meeting Type

Contested-Annual

Ticker Symbol

ILMN

 

Meeting Date

18-Apr-2012

ISIN

US4523271090

 

Agenda

933571110 - Management

Record Date

08-Mar-2012

 

Holding Recon Date

08-Mar-2012

City / Country

/

United States

Vote Deadline Date

17-Apr-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

01

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      A. BLAINE BOWMAN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      KARIN EASTHAM

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      JAY T. FLATLEY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      WILLIAM H. RASTETTER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

02

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 30, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

03

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

04

 

ROCHE’S PROPOSAL TO AMEND OUR BYLAWS TO INCREASE THE NUMBER OF DIRECTORS ON THE BOARD OF DIRECTORS.

 

Against

 

Yes

 

For

 

Shareholder

 



 

05

 

ROCHE’S PROPOSAL TO AMEND THE BYLAWS TO REQUIRE THAT NEWLY CREATED DIRECTORSHIPS BE FILLED ONLY BY A STOCKHOLDER VOTE.

 

Against

 

Yes

 

Against

 

Shareholder

 

 

 

 

 

 

 

 

 

 

 

6A

 

ROCHE’S PROPOSAL TO FILL THE TWO NEWLY CREATED DIRECTORSHIPS WITH ITS NOMINEES, IF PROPOSAL 4 IS APPROVED EARL (DUKE) COLLIER, JR.

 

For

 

Yes

 

Abstain

 

Management

 

 

 

 

 

 

 

 

 

 

 

6B

 

ROCHE’S PROPOSAL TO FILL THE TWO NEWLY CREATED DIRECTORSHIPS WITH ITS NOMINEES, IF PROPOSAL 4 IS APPROVED DAVID DODD

 

For

 

Yes

 

Abstain

 

Management

 

 

 

 

 

 

 

 

 

 

 

7

 

ROCHE’S PROPOSAL TO REPEAL ANY BYLAW AMENDMENTS ADOPTED BY ILLUMINA’S BOARD OF DIRECTORS WITHOUT STOCKHOLDER APPROVAL AFTER APRIL 22, 2010.

 

Against

 

Yes

 

Against

 

Shareholder

 

IMPAX LABORATORIES, INC.

 

Security

45256B101

 

Meeting Type

Annual

Ticker Symbol

IPXL

 

Meeting Date

22-May-2012

ISIN

US45256B1017

 

Agenda

933606658 - Management

Record Date

05-Apr-2012

 

Holding Recon Date

05-Apr-2012

City / Country

/

United States

Vote Deadline Date

21-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      LESLIE Z. BENET, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      ROBERT L. BURR

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      ALLEN CHAO, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      N. TEN FLEMING, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      LARRY HSU, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6      MICHAEL MARKBREITER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7      PETER R. TERRERI

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO APPROVE, BY NON-BINDING VOTE, EXECUTIVE COMPENSATION.

 

For

 

Yes

 

For

 

Management

 



 

3.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

INTELLIPHARMACEUTICALS INTERNATIONAL, INC.

 

Security

458175101

 

Meeting Type

Special

Ticker Symbol

IPCI

 

Meeting Date

29-Mar-12

Record Date

N/A

 

 

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

TO ELECT DIRECTOR DR. ISLA ODIDI

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT DIRECTOR DR. AMINA ODIDI

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT DIRECTOR JOHN ALLPORT

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT DIRECTOR BAHADUR MADHANI

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT DIRECTOR KENNETH KEIRSTEAD

 

For

 

Yes

 

For

 

Management

1

 

TO ELECT DIRECTOR DR. ELDON R. SMITH

 

For

 

Yes

 

For

 

Management

2

 

TO APPROVE THE REAPPOINTMENT OF DELOITTE & TOUCHE AS THE AUDITOR OF THE COMPANY AND TO AUTHORIZE THE DIRECTORS TO FIX THE AUDITORS RENUMERATION

 

For

 

Yes

 

For

 

Management

3

 

THE RESOLUTION APPROVING UNALLOCATED OPTIONS, RIGHTS AND ENTITLEMENTS UNDER THE COMPANY’S STOCK OPTION PLAN AS SET OUT IN THE ACCOMPANYING MANAGEMENT PROXY CIRCULAR

 

For

 

Yes

 

For

 

Management

 

INTERLACE MEDICAL, INC

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

14-Nov-11

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

APPROVAL OF MERGER

 

For

 

Yes

 

For

 

Management

2

 

APPOINTMENT OF STOCKHOLDER’S REPRESENTATIVE

 

For

 

Yes

 

For

 

Management

3

 

GENERAL RESOLUTIONS THAT THE OFFICERS OF THE COMPANY BE AUTHORIZED AND DIRECTED, FOR OR ON BEHALF OF THE COMPANY TO FILE, EXECUTE, VERIFY, ACKNOWLEDGE AND DELIVER ANY AND ALL SUCH CERTIFICATES PURSUANT TO THE MERGER AGREEMENT

 

For

 

Yes

 

For

 

Management

 

KERYX BIOPHARMACEUTICALS, INC.

 

Security

492515101

 

Meeting Type

Annual

Ticker Symbol

KERX

 

Meeting Date

19-Jun-2012

ISIN

US4925151015

 

Agenda

933625432 - Management

Record Date

24-Apr-2012

 

Holding Recon Date

24-Apr-2012

City / Country

/

United States

Vote Deadline Date

18-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      RON BENTSUR

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      KEVIN J. CAMERON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      JOSEPH FECZKO M.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      WYCHE FOWLER, JR.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      JACK KAYE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6      MICHAEL P. TARNOK

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

THE RATIFICATION OF APPOINTMENT OF UHY LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN OUR PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 



 

LIFE TECHNOLOGIES CORPORATION

 

Security

53217V109

 

Meeting Type

Annual

Ticker Symbol

LIFE

 

Meeting Date

26-Apr-2012

ISIN

US53217V1098

 

Agenda

933557994 - Management

Record Date

27-Feb-2012

 

Holding Recon Date

27-Feb-2012

City / Country

/

United States

Vote Deadline Date

25-Apr-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.1

 

ELECTION OF DIRECTOR: DONALD W. GRIMM

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1.2

 

ELECTION OF DIRECTOR: ORA H. PESCOVITZ, M.D.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1.3

 

ELECTION OF DIRECTOR: PER A. PETERSON, PH.D.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2

 

RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

APPROVAL OF A NON-BINDING ADVISORY RESOLUTION REGARDING THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2011 (NAMED EXECUTIVE OFFICERS).

 

For

 

Yes

 

For

 

Management

 

MAP PHARMACEUTICALS, INC.

 

Security

56509R108

 

Meeting Type

Annual

Ticker Symbol

MAPP

 

Meeting Date

17-May-2012

ISIN

US56509R1086

 

Agenda

933605846 - Management

Record Date

02-Apr-2012

 

Holding Recon Date

02-Apr-2012

City / Country

/

United States

Vote Deadline Date

16-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      THOMAS A. ARMER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      BERNARD J. KELLEY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      SCOTT R. WARD

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

For

 

Yes

 

For

 

Management

 



 

3.

 

APPROVAL, BY NON-BINDING VOTE, OF THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS OF MAP PHARMACEUTICALS, INC.

 

For

 

Yes

 

For

 

Management

 

MEDIVATION, INC.

 

Security

58501N101

 

Meeting Type

Annual

Ticker Symbol

MDVN

 

Meeting Date

01-Jul-2011

ISIN

US58501N1019

 

Agenda

933461509 - Management

Record Date

13-May-2011

 

Holding Recon Date

13-May-2011

City / Country

/

United States

Vote Deadline Date

30-Jun-2011

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      DANIEL D. ADAMS

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      GREGORY H. BAILEY, M.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      KIM D. BLICKENSTAFF

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      DAVID T. HUNG, M.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      W. ANTHONY VERNON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2011.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4

 

TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF STOCKHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

1 Year

 

Yes

 

1 Year

 

Management

 



 

MOMENTA PHARMACEUTICALS, INC.

 

Security

60877T100

 

Meeting Type

Annual

Ticker Symbol

MNTA

 

Meeting Date

13-Jun-2012

ISIN

US60877T1007

 

Agenda

933624036 - Management

Record Date

16-Apr-2012

 

Holding Recon Date

16-Apr-2012

City / Country

/

United States

Vote Deadline Date

12-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      JOHN K. CLARKE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      JAMES R. SULAT

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      CRAIG A. WHEELER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE COMPANY’S BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO VOTE ON A NON-BINDING ADVISORY RESOLUTION ON THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

For

 

Yes

 

Against

 

Management

 

MYLAN INC.

 

Security

628530107

 

Meeting Type

Annual

Ticker Symbol

MYL

 

Meeting Date

04-May-2012

ISIN

US6285301072

 

Agenda

933598572 - Management

Record Date

23-Mar-2012

 

Holding Recon Date

23-Mar-2012

City / Country

/

United States

Vote Deadline Date

03-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      ROBERT J. COURY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      RODNEY L. PIATT, C.P.A.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3      HEATHER BRESCH

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4      WENDY CAMERON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5      ROBERT J. CINDRICH

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6      NEIL DIMICK, C.P.A.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7      DOUGLAS J. LEECH C.P.A.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8      JOSEPH C. MAROON, MD

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9      MARK W. PARRISH

 

For

 

Yes

 

For

 

 

 



 

 

 

10    C.B. TODD

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11    R.L. VANDERVEEN PHD RPH

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

RATIFY APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

APPROVE AN AMENDED AND RESTATED 2003 LONG-TERM INCENTIVE PLAN

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

ADVISORY VOTE ON EXECUTIVE COMPENSATION

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

5.

 

SHAREHOLDER PROPOSAL - DISCLOSURE OF POLITICAL CONTRIBUTIONS

 

Against

 

Yes

 

Against

 

Shareholder

 

 

 

 

 

 

 

 

 

 

 

6.

 

SHAREHOLDER PROPOSAL - SEPARATION OF CHAIRMAN AND CEO POSITIONS

 

Against

 

Yes

 

Against

 

Shareholder

 

NEUROCRINE BIOSCIENCES, INC.

 

Security

64125C109

 

Meeting Type

Annual

Ticker Symbol

NBIX

 

Meeting Date

23-May-2012

ISIN

US64125C1099

 

Agenda

933612663 - Management

Record Date

02-Apr-2012

 

Holding Recon Date

02-Apr-2012

City / Country

/

United States

Vote Deadline Date

22-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1      W. THOMAS MITCHELL

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2      JOSEPH A. MOLLICA

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 



 

NPS PHARMACEUTICALS, INC.

 

Security

62936P103

 

Meeting Type

Annual 

Ticker Symbol

NPSP

 

Meeting Date

16-May-2012

ISIN

US62936P1030

 

Agenda

933593281 - Management

Record Date

26-Mar-2012

 

Holding Recon Date

26-Mar-2012

City / Country

/

United States

Vote Deadline Date

15-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  MICHAEL W. BONNEY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  COLIN BROOM

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3                  GEORGES GEMAYEL

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4                  PEDRO GRANADILLO

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5                  JAMES G. GRONINGER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6                  FRANCOIS NADER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7                  RACHEL R. SELISKER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8                  PETER G. TOMBROS

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

ONCOGENEX PHARMACEUTICALS, INC

 

Security

68230A106

 

Meeting Type

Annual

Ticker Symbol

OGXI

 

Meeting Date

31-May-2012

ISIN

US68230A1060

 

Agenda

933618615 - Management

Record Date

02-Apr-2012

 

Holding Recon Date

02-Apr-2012

City / Country

/

United States

Vote Deadline Date

30-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  SCOTT CORMACK

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  NEIL CLENDENINN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3                  JACK GOLDSTEIN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4                  MARTIN MATTINGLY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5                  STEWART PARKER

 

For

 

Yes

 

For

 

 

 



 

 

 

6                  DAVID SMITH

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

ONYX PHARMACEUTICALS, INC.

 

Security

683399109

 

Meeting Type

Annual

Ticker Symbol

ONXX

 

Meeting Date

21-May-2012

ISIN

US6833991093

 

Agenda

933589179 - Management

Record Date

22-Mar-2012

 

Holding Recon Date

22-Mar-2012

City / Country

/

United States

Vote Deadline Date

18-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  PAUL GODDARD

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  ANTONIO J. GRILLO LOPEZ

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3                  WENDELL WIERENGA

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S 2005 EQUITY PLAN TO, AMONG OTHER THINGS, INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 2,000,000 SHARES.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 



 

PALOMAR MEDICAL TECHNOLOGIES, INC.

 

Security

697529303

 

Meeting Type

Annual 

Ticker Symbol

PMTI

 

Meeting Date

16-May-2012

ISIN

US6975293035

 

Agenda

933585183 - Management

Record Date

22-Mar-2012

 

Holding Recon Date

22-Mar-2012

City / Country

/

United States

Vote Deadline Date

15-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  JOSEPH P. CARUSO

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  JEANNE COHANE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3                  DAMIAN N. DELL’ANNO

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4                  NICHOLAS P. ECONOMOU

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5                  JAMES G. MARTIN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6                  A. NEIL PAPPALARDO

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7                  LOUIS P. VALENTE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO APPROVE AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

TO CONSIDER AND ACT UPON A STOCKHOLDER PROPOSAL REGARDING MAJORITY VOTING IN DIRECTOR ELECTIONS.

 

Against

 

Yes

 

Against

 

Shareholder

 

PALYON MEDICAL CORPORATION

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

25-Apr-12

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

APPROVAL OF BRIDGE FINANCING

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2

 

AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

APPROVAL OF INCREASE OF SHARES RESERVED UNDER 2009 STOCK OPTION AND INCENTIVE PLAN

 

For

 

Yes

 

For

 

Management

 



 

PHT CORPORATION

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

27-Jul-11

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

APPROVAL THAT THE CORPORTATION IS AUTHORIZED TO ENTER INTO, EXECUTE AND DELIVER, AND PERFORM ITS OBLIGATIONS UNDER, A FIRST LOAN MODIFICATION AGREEMENT

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2

 

APPROVAL THAT THE CORPORATION IS AUTHORIZED AND EMPOWERED, AS SECURITY FOR ANY AND ALL OBLIGATIONS OF THE CORPORATION IN CONNECTION WITH THE FIRST LOAN MODIFICATION AGREEMENT

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

APPROVAL THAT THE PRESIDENT, CEO AND CFO ACT AS AUTHORIZED OFFICERS

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4

 

APPROVAL THAT THE AUTHORIZED OFFICERS OF THE CORPORATION BE AUTHORIZED AND EMPOWERED TO EXECUTE AND DELIVER ANY AGREEMENTS ON BEHALF OF THE CORPORATION

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

5

 

APPROVAL THAT ALL ACTIONS PREVIOUSLY TAKEN BY AN OFFICER IN CONNECTION WITH THE FOREGOING RESOLUTIONS BE APPROVED, ADOPTED AND RATIFIED IN ALL RESPECTS AS THE ACTS AND DEEDS OF THE CORPORATION

 

For

 

Yes

 

For

 

Management

 

PUMA BIOTECHNOLOGY, INC.

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

4-Oct-11

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

AMENDMENT TO THE CERTIFICATE OF INCORPORATION

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2

 

GENERAL AUTHORITY AND RATIFICATION

 

For

 

Yes

 

For

 

Management

 



 

PUMA BIOTECHNOLOGY, INC

 

Security

74587V107

 

Meeting Type

Annual

Ticker Symbol

PBYI

 

Meeting Date

13-Jun-12

Record Date

16-Apr-12

 

 

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

TO ELECT DIRECTORS ALAN H. AUERBACH, THOMAS R. MALLEY AND JAY M. MOYES

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2

 

ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN THE PROXY MATERIALS

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

ADVISORY VOTE TO APPROVE THE FREQUENCY OF FUTURE VOTES ON OUR EXECUTIVE COMPENSATION

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4

 

RATIFICATION OF PKF CERIFIED PUBLIC ACCOUNTANTS AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012

 

For

 

Yes

 

For

 

Management

 

REGENERON PHARMACEUTICALS, INC.

 

Security

75886F107

 

Meeting Type

Annual

Ticker Symbol

REGN

 

Meeting Date

08-Jun-2012

ISIN

US75886F1075

 

Agenda

933614352 - Management

Record Date

11-Apr-2012

 

Holding Recon Date

11-Apr-2012

City / Country

/

United States

Vote Deadline Date

07-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  CHARLES A. BAKER

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  MICHAEL S. BROWN, M.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3                  ARTHUR F. RYAN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4                  GEORGE L. SING

 

For

 

Yes

 

For

 

 

 



 

 

 

5                  MARC TESSIER-LAVIGNE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

SANTARUS, INC.

 

Security

802817304

 

Meeting Type

Annual

Ticker Symbol

SNTS

 

Meeting Date

13-Jun-2012

ISIN

US8028173040

 

Agenda

933619554 - Management

Record Date

16-Apr-2012

 

Holding Recon Date

16-Apr-2012

City / Country

/

United States

Vote Deadline Date

12-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  GERALD T. PROEHL

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  DAVID F. HALE

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3                  TED W. LOVE, M.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 



 

SHIRE PLC

 

Security

82481R106

 

Meeting Type

Annual

Ticker Symbol

SHPGY

 

Meeting Date

24-Apr-2012

ISIN

US82481R1068

 

Agenda

933576730 - Management

Record Date

16-Mar-2012

 

Holding Recon Date

16-Mar-2012

City / Country

/

United States

Vote Deadline Date

16-Apr-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

O1

 

TO RECEIVE THE COMPANY’S ACCOUNTS FOR THE YEAR ENDED DECEMBER 31, 2011 AND REPORTS OF THE DIRECTORS AND THE AUDITOR.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O2

 

TO APPROVE THE DIRECTORS’ REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2011.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O3

 

TO RE-ELECT WILLIAM BURNS AS A DIRECTOR OF THE COMPANY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O4

 

TO RE-ELECT MATTHEW EMMENS AS A DIRECTOR OF THE COMPANY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O5

 

TO RE-ELECT DR. DAVID GINSBURG AS A DIRECTOR OF THE COMPANY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O6

 

TO RE-ELECT GRAHAM HETHERINGTON ASA DIRECTOR OF THE COMPANY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O7

 

TO RE-ELECT DAVID KAPPLER AS A DIRECTOR OF THE COMPANY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O8

 

TO RE-ELECT ANNE MINTO AS A DIRECTOR OF THE COMPANY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O9

 

TO RE-ELECT ANGUS RUSSELL AS A DIRECTOR OF THE COMPANY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O10

 

TO RE-ELECT DAVID STOUT AS A DIRECTOR OF THE COMPANY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O11

 

TO ELECT SUSAN KILSBY AS A DIRECTOR OF THE COMPANY.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O12

 

TO RE-APPOINT DELOITTE LLP AS THE COMPANY’S AUDITOR UNTIL THE CONCLUSION OF THE ANNUAL GENERAL MEETING OF THE COMPANY TO BE HELD IN 2013.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

O13

 

TO AUTHORIZE THE AUDIT, COMPLIANCE & RISK COMMITTEE OF THE BOARD TO DETERMINE THE REMUNERATION OF THE AUDITOR.

 

For

 

Yes

 

For

 

Management

 



 

O14

 

TO RESOLVE THAT THE AUTHORITY TO ALLOT RELEVANT SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION) CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (B) OF THE COMPANY’S ARTICLES OF ASSOCIATION BE RENEWED. ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

Against

 

N/A

 

Abstain

 

Management

 

 

 

 

 

 

 

 

 

 

 

S15

 

TO RESOLVE THAT, SUBJECT TO THE PASSING OF RESOLUTION 14, THE AUTHORITY TO ALLOT EQUITY SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION) WHOLLY FOR CASH, CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (D) OF THE COMPANY’S ARTICLES OF ASSOCIATION BE RENEWED, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

Against

 

N/A

 

Abstain

 

Management

 

 

 

 

 

 

 

 

 

 

 

S16

 

TO RESOLVE THAT THE COMPANY BE AND IS HEREBY GENERALLY AND UNCONDITIONALLY AUTHORIZED, PURSUANT TO ARTICLE 57 OF THE COMPANIES (JERSEY) LAW 1991 TO MAKE MARKET PURCHASES OF ORDINARY SHARES IN THE CAPITAL OF THE COMPANY, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

S17

 

TO RESOLVE THAT A GENERAL MEETING OF THE COMPANY, OTHER THAN AN ANNUAL GENERAL MEETING, MAY BE CALLED ON NOT LESS THAN 14 CLEAR DAYS’ NOTICE.

 

For

 

Yes

 

For

 

Management

 



 

TARGACEPT, INC.

 

Security

87611R306

 

Meeting Type

Annual

Ticker Symbol

TRGT

 

Meeting Date

31-May-2012

ISIN

US87611R3066

 

Agenda

933609236 - Management

Record Date

12-Apr-2012

 

Holding Recon Date

12-Apr-2012

City / Country

/

United States

Vote Deadline Date

30-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  G. STEVEN BURRILL

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  ERROL B. DE SOUZA

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3                  MARK SKALETSKY

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012

 

For

 

Yes

 

For

 

Management

 

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

 

Security

881624209

 

Meeting Type

Annual

Ticker Symbol

TEVA

 

Meeting Date

19-Sep-2011

ISIN

US8816242098

 

Agenda

933499104 - Management

Record Date

10-Aug-2011

 

Holding Recon Date

10-Aug-2011

City / Country

/

United States

Vote Deadline Date

08-Sep-2011

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

01

 

APPROVE RESOLUTION OF THE BOARD TO DECLARE & DISTRIBUTE CASH DIVIDEND FOR YEAR DECEMBER 31, 2010, PAID IN FOUR INSTALLMENTS IN AN AGGREGATE AMOUNT OF NIS 2.90 PER ORDINARY SHARE (OR ADS).

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2A

 

TO APPOINT MR. CHAIM HURVITZ TO THE BOARD OF DIRECTORS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2B

 

TO APPOINT MR. ORY SLONIM TO THE BOARD OF DIRECTORS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2C

 

TO APPOINT MR. DAN SUESSKIND TO THE BOARD OF DIRECTORS.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3A

 

APPOINT MR. JOSEPH (YOSSI) NITZANI AS A STATUTORY INDEPENDENT DIRECTOR, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 



 

3B

 

APPOINT PROF. DAFNA SCHWARTZ AS A STATUTORY INDEPENDENT DIRECTOR, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

04

 

APPOINT KESSELMAN & KESSELMAN, MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

05

 

TO APPROVE THE PURCHASE OF DIRECTORS’ & OFFICERS’ LIABILITY INSURANCE, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

6A

 

TO APPROVE AN INCREASE IN THE REMUNERATION FOR PROF. MOSHE MANY IN HIS CAPACITY AS VICE CHAIRMAN OF THE BOARD OF DIRECTORS, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

For

 

Yes

 

Against

 

Management

 

 

 

 

 

 

 

 

 

 

 

6B

 

APPROVE REIMBURSEMENT OF EXPENSES TO DR. PHILLIP FROST, CHAIRMAN OF BOARD, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

For

 

Yes

 

Against

 

Management

 

THERMO FISHER SCIENTIFIC INC.

 

Security

883556102

 

Meeting Type

Annual

Ticker Symbol

TMO

 

Meeting Date

23-May-2012

ISIN

US8835561023

 

Agenda

933590172 - Management

Record Date

26-Mar-2012

 

Holding Recon Date

26-Mar-2012

City / Country

/

United States

Vote Deadline Date

22-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1A.

 

ELECTION OF DIRECTOR: C. MARTIN HARRIS

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1B.

 

ELECTION OF DIRECTOR: JUDY C. LEWENT

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1C.

 

ELECTION OF DIRECTOR: JIM P. MANZI

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1D.

 

ELECTION OF DIRECTOR: LARS R. SORENSEN

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1E.

 

ELECTION OF DIRECTOR: ELAINE S. ULLIAN

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.

 

AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.

 

For

 

Yes

 

For

 

Management

 



 

3.

 

RATIFICATION OF THE AUDIT COMMITTEE’S SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR 2012.

 

For

 

Yes

 

For

 

Management

 

TIBION CORPORATION

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

23-May-12

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

APPROVE THE AMENDMENT AND RESTATED CERTIFICATE OF INCORPORATION

 

For

 

Yes

 

For

 

Management

 

UNITED THERAPEUTICS CORPORATION

 

Security

91307C102

 

Meeting Type

Annual

Ticker Symbol

UTHR

 

Meeting Date

26-Jun-2012

ISIN

US91307C1027

 

Agenda

933631055 - Management

Record Date

27-Apr-2012

 

Holding Recon Date

27-Apr-2012

City / Country

/

United States

Vote Deadline Date

25-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  MARTINE ROTHBLATT

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  LOUIS SULLIVAN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3                  RAY KURZWEIL

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

APPROVAL OF THE UNITED THERAPEUTICS CORPORATION EMPLOYEE STOCK PURCHASE PLAN

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS UNITED THERAPEUTICS CORPORATION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2012

 

For

 

Yes

 

For

 

Management

 

VERASTEM, INC.

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Date

14-Nov-11

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2

 

WAVIER OF PREEMPTIVE RIGHTS

 

For

 

Yes

 

For

 

Management

 



 

VERASTEM, INC.

 

Security

N/A

 

Meeting Type

Action by Written Consent

Ticker Symbol

N/A

 

Meeting Date

15-Nov-11

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

APPROVE THE PIONARD LICENSE AGREEMENT

 

For

 

Yes

 

For

 

Management

 

VERASTEM, INC.

 

Security

0001526119

 

Meeting Type

Annual

Ticker Symbol

VSTM

 

Meeting Date

18-Jan-12

Record Date

19-Dec-11

 

 

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

TO ELECT DIRECTORS RICH ALDRICH, JOHN K. CLARKE, ANSBERT GADICKE, M.D., STEPHEN KRAUS, HENRI TERMEER AND CHRISTOPH WESTPHAL, M.D., PH.D.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2

 

TO CONDUCT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE ANNUAL MEETING OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF

 

For

 

Yes

 

For

 

Management

 

VERTEX PHARMACEUTICALS INCORPORATED

 

Security

92532F100

 

Meeting Type

Annual

Ticker Symbol

VRTX

 

Meeting Date

16-May-2012

ISIN

US92532F1003

 

Agenda

933606165 - Management

Record Date

19-Mar-2012

 

Holding Recon Date

19-Mar-2012

City / Country

/

United States

Vote Deadline Date

15-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  JEFFREY M. LEIDEN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  BRUCE I. SACHS

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

THE APPROVAL OF THE AMENDMENT TO OUR AMENDED AND RESTATED 2006 STOCK AND OPTION PLAN THAT INCREASES THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 3,000,000.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

THE APPROVAL OF THE AMENDMENT TO OUR EMPLOYEE STOCK PURCHASE PLAN THAT INCREASES THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 2,500,000.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

5.

 

ADVISORY VOTE ON OUR EXECUTIVE COMPENSATION PROGRAM.

 

For

 

Yes

 

For

 

Management

 

VIVUS, INC.

 

Security

928551100

 

Meeting Type

Annual

Ticker Symbol

VVUS

 

Meeting Date

15-Jun-2012

ISIN

US9285511005

 

Agenda

933627400 - Management

Record Date

20-Apr-2012

 

Holding Recon Date

20-Apr-2012

City / Country

/

United States

Vote Deadline Date

14-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  LELAND F. WILSON

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  PETER Y. TAM

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3                  MARK B. LOGAN

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4                  CHARLES J. CASAMENTO

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5                  LINDA M D SHORTLIFFE MD

 

For

 

Yes

 

For

 

 

 



 

 

 

6                  ERNEST MARIO, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPANY’S EXECUTIVE COMPENSATION.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3

 

RATIFICATION OF THE APPOINTMENT OF OUM & CO. LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF VIVUS, INC. FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012

 

For

 

Yes

 

For

 

Management

 

WARNER CHILCOTT PUBLIC LIMITED COMPANY

 

Security

G94368100

 

Meeting Type

Annual

Ticker Symbol

WCRX

 

Meeting Date

08-May-2012

ISIN

IE00B446CM77

 

Agenda

933593623 - Management

Record Date

12-Mar-2012

 

Holding Recon Date

12-Mar-2012

City / Country

/

United States

Vote Deadline Date

07-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1A)

 

ELECTION OF DIRECTOR: JAMES H. BLOEM

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1B)

 

ELECTION OF DIRECTOR: ROGER M. BOISSONNEAULT

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1C)

 

ELECTION OF DIRECTOR: JOHN A. KING, PH.D.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1D)

 

ELECTION OF DIRECTOR: PATRICK J. O’SULLIVAN

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO APPROVE THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, A REGISTERED PUBLIC ACCOUNTING FIRM, AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012, AND TO AUTHORIZE THE BOARD OF DIRECTORS TO DETERMINE THE AUDITORS’ REMUNERATION.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, EXECUTIVE COMPENSATION.

 

For

 

Yes

 

For

 

Management

 



 

WATSON PHARMACEUTICALS, INC.

 

Security

942683103

 

Meeting Type

Annual

Ticker Symbol

WPI

 

Meeting Date

11-May-2012

ISIN

US9426831031

 

Agenda

933582517 - Management

Record Date

16-Mar-2012

 

Holding Recon Date

16-Mar-2012

City / Country

/

United States

Vote Deadline Date

10-May-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1A.

 

ELECTION OF DIRECTOR: JACK MICHELSON

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1B.

 

ELECTION OF DIRECTOR: RONALD R. TAYLOR

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

1C.

 

ELECTION OF DIRECTOR: ANDREW L. TURNER

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, NAMED EXECUTIVE OFFICER COMPENSATION.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

TO APPROVE AN ANNUAL INCENTIVE PLAN WHICH, IF APPROVED, IS GENERALLY INTENDED TO ALLOW COMPENSATION PAID THEREUNDER TO COVERED EMPLOYEES TO QUALIFY AS “QUALIFIED PERFORMANCE-BASED COMPENSATION” WITHIN THE MEANING OF 162(M) OF THE UNITED STATES INTERNAL REVENUE CODE (AS AMENDED) (THE “CODE”).

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

ZOGENIX, INC.

 

Security

98978L105

 

Meeting Type

Annual

Ticker Symbol

ZGNX

 

Meeting Date

06-Jun-2012

ISIN

US98978L1052

 

Agenda

933639126 - Management

Record Date

19-Apr-2012

 

Holding Recon Date

19-Apr-2012

City / Country

/

United States

Vote Deadline Date

05-Jun-2012

SEDOL(s)

 

 

Quick Code

 

 

Item

 

Proposal

 

Management
Recommends

 

Voted

 

Vote
Cast

 

Sponsor

 

 

 

 

 

 

 

 

 

 

 

1.

 

DIRECTOR

 

 

 

 

 

 

 

Management

 

 

 

 

 

 

 

 

 

 

 

 

 

1                  JAMES C. BLAIR, PH.D.

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2                  STEPHEN J. FARR, PH.D.

 

For

 

Yes

 

For

 

 

 



 

 

 

3                  A M MINOCHERHOMJEE, PHD

 

For

 

Yes

 

For

 

 

 

 

 

 

 

 

 

 

 

 

 

2.

 

RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS ZOGENIX’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

3.

 

APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S 2010 EQUITY INCENTIVE AWARD PLAN.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

4.

 

APPROVAL OF AN AMENDMENT TO THE COMPANY’S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF COMMON STOCK FROM 100,000,000 TO 200,000,000.

 

For

 

Yes

 

For

 

Management

 



 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant)

H&Q Life Sciences Investors

 

By (Signature and Title)*

 

 

 

 

 

 

/s/ Daniel R. Omstead

 

(Daniel R. Omstead, President)

 

Date

8/31/12

 


*Print the name and title of each signing officer under his or her signature.

 

2